A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We are a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Our products, services and technologies are designed to achieve our goal of providing better clinical outcomes at a lower overall cost for patients regardless of where they receive care. Through our two operating segments, Sanara Surgical and Tissue Health Plus (“THP”), we strive to be one of the most innovative and comprehensive providers of effective surgical, wound and skincare solutions and are continually seeking to expand our offerings for patients requiring treatments across the entire continuum of care in the United States. Reportable Segments Historically, we managed our business on the basis of one operating and reportable segment.
| Metric | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Revenue | 94M | 46M | 24M | 16M | 12M | 5.8M |
| Net Income | -38M | -7.9M | -7.9M | -4.4M | -2.8M | -732K |
| EPS | $-4.25 | $-0.95 | $-1.08 | $-0.76 | $-1.32 | $-0.00 |
| Free Cash Flow | -3.4M | -5.7M | -5.0M | -4.6M | -2.4M | 269K |
| ROIC | 10.3% | -19.0% | -25.9% | -70.8% | -34.7% | -65.8% |
| Gross Margin | 92.0% | 86.1% | 90.4% | 89.6% | 89.7% | 91.3% |
| Debt/Equity | 7.33 | 0.46 | 0.20 | 0.65 | 0.23 | 1.74 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 4.7M | -12M | -7.4M | -5.0M | -2.7M | -502K |
| Operating Margin | 5.0% | -26.7% | -30.6% | -32.3% | -23.3% | -8.6% |
| ROE | -613.4% | -21.9% | -43.1% | -70.8% | -42.5% | -120.5% |
| Shares Outstanding | 9M | 8M | 7M | 6M | 8M | 2M |
Sanara MedTech Inc. passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 89.4%. At current prices, the estimated annualized return to fair value is -17.9%.
Sanara MedTech Inc. (SMTI) has a 5-year average return on invested capital (ROIC) of -43.2%. This is below average and may indicate limited pricing power.
Sanara MedTech Inc. (SMTI) has a market capitalization of $165M. It is classified as a small-cap stock.
Sanara MedTech Inc. (SMTI) does not currently pay a regular dividend.
Sanara MedTech Inc. (SMTI) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
Sanara MedTech Inc. (SMTI) reported annual revenue of $46 million in its most recent fiscal year, based on SEC EDGAR filings.
Sanara MedTech Inc. (SMTI) has a net profit margin of -17.3%. The company is currently unprofitable.
Sanara MedTech Inc. (SMTI) generated $-6 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Sanara MedTech Inc. (SMTI) has a debt-to-equity ratio of 0.46. This indicates a conservatively financed balance sheet.
Sanara MedTech Inc. (SMTI) reported earnings per share (EPS) of $-0.95 in its most recent fiscal year.
Sanara MedTech Inc. (SMTI) has a return on equity (ROE) of -21.9%. A negative ROE may indicate losses or negative equity.
Sanara MedTech Inc. (SMTI) has a 5-year average gross margin of 89.4%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 12 years of financial data for Sanara MedTech Inc. (SMTI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Sanara MedTech Inc. (SMTI) has a book value per share of $4.99, based on its most recent annual SEC filing.